Early postmenopausal women with cardiovascular risk factors improve microvascular dysfunction after acute estradiol administration

Menopause

Volumn 19, Issue 6, 2012, Pages 672-679

  Clapauch, Ruth ^a,b   Mecenas, Anete S ^a   Maranhão, Priscila A ^a   Bouskela, Eliete ^a  

^a STATE UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b HOSPITAL DA LAGOA   (Brazil)

Author keywords

Cardiovascular; Diabetes; Estrogen; Hot flashes; Hypertension; Menopause

Indexed keywords

ESTRADIOL;

ADULT; ARTERIAL STIFFNESS; ARTERY OCCLUSION; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CIGARETTE SMOKING; CONTROLLED STUDY; DIABETES MELLITUS; ERYTHROCYTE; FEMALE; HOT FLUSH; HUMAN; HYPERTENSION; ORAL CONTRACEPTION; POSTMENOPAUSE; VASODILATATION;

ADMINISTRATION, INTRANASAL; ADULT; BLOOD FLOW VELOCITY; CARDIOVASCULAR DISEASES; DIABETES MELLITUS; ENDOTHELIUM, VASCULAR; ESTRADIOL; FEMALE; HUMANS; HYPERTENSION; MICROVESSELS; MIDDLE AGED; POSTMENOPAUSE; RISK FACTORS;

EID: 84862137596     PISSN: 10723714     EISSN: 15300374     Source Type: Journal    
DOI: 10.1097/gme.0b013e31823a8f43     Document Type: Article

References (48)

1. Mendelsohn ME, Karas RH. The protective effects of estrogen on the cardiovascular system. N Engl J Med 1999;340:1801-1811.
2. Kim KH, Bender JR. Membrane-initiated actions of estrogen on the endothelium. Mol Cell Endocrinol 2009;308:3-8.
3. Clapauch R, Mecenas AS, Maranhão PA, Bouskela E. Endothelialmediated microcirculatory responses to an acute estradiol test are influenced by time since menopause, cumulative hormone exposure and vasomotor symptoms. Menopause 2010;17:749-757.
4. Rubanyi GM, Freay AD, Kauser K, et al. Vascular estrogen receptors and endothelium-derived nitric oxide production in the mouse aorta. Gender difference and effect of estrogen receptor gene disruption. J Clin Invest 1997;99:2429-2437.
5. Post WS, Goldschmidt-Clermont PJ, Wilhide CC, et al. Methylation of the estrogen receptor gene is associated with aging and atherosclerosis in the cardiovascular system. Cardiovasc Res 1999;43:985-991.
6. Santen RJ, Allred DC, Ardoin SP, et al. Endocrine Society. Postmenopausal hormone therapy: an Endocrine Society scientific statement. J Clin Endocrinol Metab 2010;95:s1-s66.
7. Wang J, Widlansky ME. Lifestyle choices and endothelial function: risk and relevance. Curr Vasc Pharmacol 2009;7:209-224.
8. Lerman A, Zeiher AM. Endothelial function: cardiac events. Circulation 2005;111:363-368.
9. Hsueh WA, Orloski L, Wyne K. Prediabetes: the importance of early identification and intervention. Postgrad Med 2010;122:129-143.
10. Ong KL, Cheung BM, Man YB, Lau CP, Lam KS. Prevalence, awareness, treatment, and control of hypertension among United States adults 1999-2004. Hypertension 2007;49:69-75.
11. Cowie CC, Rust KF, Byrd-Holt DD, et al. Prevalence of diabetes and high risk for diabetes using A1C criteria in the U.S. population in 1988-2006. Diabetes Care 2010;33:562-568.
12. Clapauch R, Mecenas AS, Maranhão PA, Bouskela E. Microcirculatory function in postmenopausal women: role of aging, hormonal exposure and metabolic syndrome. Microvasc Res 2009;78:405-412.
13. Fagrell B, Intaglietta M. The dynamics of skin microcirculation as a tool for the study of systemic diseases. Bibl Anat 1977;16:231-234.
14. Gallucci F, Russo R, Buono R, Acampora R, Madrid E, Uomo G. Indications and results of videocapillaroscopy in clinical practice. Adv Med Sci 2008;53:149-157.
15. Ostergren J, Fagrell B. Skin capillary blood cell velocity in man. Characteristics and reproducibility of the reactive hyperemia response. Int J Microcirc Clin Exp 1986;5:37-51.
16. Simoncini T, Fornari L, Mannella P, et al. Differential estrogen signaling in endothelial cells upon pulsed or continuous administration. Maturitas 2005;50:247-258.
17. Simoncini T, Mannella P, Genazzani AR. Rapid estrogen actions in the cardiovascular system. Ann N Y Acad Sci 2006;1089:424-430.
18. Klyscz T, Junger M, Jung F, Zeintl H. Cap imageVa new kind of computer-assisted video image analysis system for dynamic capillary microscopy. Biomed Tech (Berl) 1997;42:168-175.
19. Wygoda MM, Filippo RB Jr, Gomes MAS, Clapauch R. Monitorizando a terapia de reposi0ão estrogênica (TRE) na menopausa. Arq Bras Endocrinol Metab 1999;43:336-343.
20. Wilson PWF, D'Agostino RB, Levy D, Belanger AM, Silbershatz H, Kannel WB. Prediction of coronary heart disease using risk factor categories. Circulation 1998;97:1837-1847.
21. Alberti KG, Zimmet P, Shaw J. Metabolic syndromeVa new worldwide definition. A Consensus Statement from the International Diabetes Federation. Diabet Med 2006;23:469-480.
22. Collins P, Rosano G, Casey C, et al. Management of cardiovascular risk in the peri-menopausal woman: a consensus statement of European cardiologists and gynaecologists. Eur Heart J 2007;28:2028-2040.
23. Jani B, Rajkumar C. Ageing and vascular ageing. Postgrad Med J 2006; 82:357-362.
24. Kawashima S, Yokoyama M. Dysfunction of endothelial nitric oxide synthase and atherosclerosis. Arterioscler Thromb Vasc Biol 2004;24:998-1005.
25. Garcia PM, Gimenez J, Bonacasa B, et al. 17A-Estradiol exerts a beneficial effect on coronary vascular remodeling in the early stages of hypertension in spontaneously hypertensive rats. Menopause 2005;12:453-459.
26. Karas R, Clarkson TB. Considerations in interpreting the cardiovascular effects of hormone replacement therapy observed in the WHI: timing is everything. Menopausal Med 2003;10:8-12.
27. Rossouw JE, Anderson GL, Prentice RL, et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA 2002;288:321-333.
28. Anderson GL, Limacher M, Assaf AR, et al. Women's Health Initiative Steering Committee. Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial. JAMA 2004;291:1701-1712.
29. Manson JE, Allison MA, Rossouw JE, et al. Estrogen therapy and coronaryartery calcification. N Engl JMed 2007;356:2591-2602.
30. Lima SM, Aldrighi JM, Consolim-Colombo FM, et al. Acute administration of 17A-estradiol improves endothelium-dependent vasodilation in postmenopausal women. Maturitas 2005;50:266-274.
31. Lee SJ, Lee DW, Kim KS, Lee IK. Effect of estrogen on endothelial dysfunction in postmenopausal women with diabetes. Diabetes Res Clin Pract 2001;54:S81-S92.
32. Yoshida M, Tomiyama H, Yamada J, et al. Relationship of insulin resistance to macro-and microvasculature reactivity in hypertension. Am J Hypertens 2010;23:495-500.
33. Meyer MF, Lieps D, Schatz H, Pfohl M. Impaired flow-mediated vasodilatation in type 2 diabetes: lack of relation to microvascular dysfunction. Microvasc Res 2008;76:61-65.
34. Tsutsumi S, Zhang X, Takata K, et al. Differential regulation of the inducible nitric oxide synthase gene by estrogen receptors 1 and 2. J Endocrinol 2008;199:267-273.
35. Chow RW, Handelsman DJ, Ng MK. Minireview: rapid actions of sex steroids in the endothelium. Endocrinology 2010;151:2411-2422.
36. Holm A, Andersson KE, Nordström I, Hellstrand P, Nilsson BO. Downregulation of endothelial cell estrogen receptor expression by the inflammation promoter LPS. Mol Cell Endocrinol 2010;319:8-13.
37. Mendelsohn ME. Estrogen actions in the cardiovascular system. Climacteric 2009;12:18-21.
38. Shokawa T, Imazu M, Yamamoto H, et al. Pulse wave velocity predicts cardiovascular mortality: findings from the Hawaii-Los Angeles-Hiroshima study. Circ J 2005;69:259-264.
39. Maldonado J, Pereira T, Polónia J, Silva JA, Morais J, Marques M; Participants in the EDIVA Project. Arterial stiffness predicts cardiovascular outcome in a low-to-moderate cardiovascular risk population: the EDIVA (Estudo de DIstensibilidade VAscular) project. J Hypertens 2011;29:669-675.
40. Thurston RC, Sowers MR, Sutton-Tyrrell K, et al. Abdominal adiposity and hot flashes among midlife women. Menopause 2008;15:429-434.
41. Thurston RC, Sutton-Tyrrell K, Everson-Rose SA, et al. Hot flashes and carotid intima media thickness among midlife women. Menopause 2011;18:352-358.
42. Thurston RC, Sutton-Tyrrell K, Everson-Rose SA, Hess R, Matthews KA. Hot flashes and subclinical cardiovascular disease: findings from the Study of Women's Health across the Nation Heart Study. Circulation 2008;118:1234-1240.
43. Freedman RR, Kruger ML, Wasson SL, Samuel L. Heart rate variability in menopausal hot flashes during sleep. Menopause 2011;18:897-900.
44. Gast GC, Samsioe GN, Grobbee DE, Nilsson PM, van der Schouw YT. Vasomotor symptoms, estradiol levels and cardiovascular risk profile in women. Maturitas 2010;66:285-290.
45. Gast GC, Pop VJ, Samsioe GN, et al. Vasomotor menopausal symptoms are associated with increased risk of coronary heart disease. Menopause 2011;18:146-151.
46. Laurent S, Cockcroft J, Van Bortel L, et al. Expert consensus document on arterial stiffness: methodological issues and clinical applications. Eur Heart J 2006;27:2588-2605.
47. Jónsdóttir LS, Sigfússon N, Gudnason V, Sigvaldason H, Thorgeirsson G. Do lipids, blood pressure, diabetes, and smoking confer equal risk of myocardial infarction in women as in men? The Reykjavik Study. J Cardiovasc Risk 2002;9:67-76.
48. Lobo RA, Clarkson TB. Different mechanisms for benefit and risk of coronary heart disease and stroke in early postmenopausal women: a hypothetical explanation. Menopause 2011;18:237-240.